SILVER SPRING, Maryland The cost of developing a drug-eluting stent (DES) has been pegged as somewhere north of $100 million, but that number has not deterred several device makers from wading into this end of the cardiovascular device pool.
DES post-approval no longer just an FDA after-thought
January 2, 2015